Literature DB >> 27471207

Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden.

Elizabeth V Arkema1, Johan Grunewald2,3, Susanna Kullberg2,3, Anders Eklund2,3, Johan Askling4,5.   

Abstract

Our objective was to estimate the contemporary incidence and prevalence of sarcoidosis using Swedish population-based register data.Adults with any sarcoidosis-coded visit were identified from the National Patient Register (hospitalisations 1964-2013 and outpatient care 2001-2013). Demographic and medication dispensing data were retrieved from national registers. We estimated the prevalence of sarcoidosis in 2013 overall and by county of residence. The incidence of sarcoidosis during 2003-2012 was estimated by sex, age, education level and year of diagnosis. Case definitions were varied to test their robustness.More than 16 000 individuals had a history of sarcoidosis in 2013. When defined as two or more sarcoidosis-coded visits, the prevalence was 160 per 100 000. Using different definitions, the prevalence ranged from 152 (requiring a specialist visit) to 215 per 100 000 (only one visit required). The highest prevalence was observed in northern less densely populated counties. The incidence was 11.5 per 100 000 per year and varied by -10% to +30% depending on case definition. The incidence peaked in males aged 30-50 years and in females aged 50-60 years, but did not differ by education level and was stable over time.This study represents the largest epidemiological investigation of sarcoidosis using population-based individual-level data. Age at diagnosis in men was 10 years younger than in women and geographical variation was observed.
Copyright ©ERS 2016.

Entities:  

Mesh:

Year:  2016        PMID: 27471207     DOI: 10.1183/13993003.00477-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  43 in total

1.  Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris.

Authors:  Boris Duchemann; Isabella Annesi-Maesano; Camille Jacobe de Naurois; Shreosi Sanyal; Pierre-Yves Brillet; Michel Brauner; Marianne Kambouchner; Sophie Huynh; Jean Marc Naccache; Raphael Borie; Jacques Piquet; Arsène Mekinian; Jerôme Virally; Yurdagul Uzunhan; Jacques Cadranel; Bruno Crestani; Olivier Fain; Francois Lhote; Robin Dhote; Nathalie Saidenberg-Kermanac'h; Paul-André Rosental; Dominique Valeyre; Hilario Nunes
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

2.  Isolated gastric sarcoidosis: a rare entity.

Authors:  Ronak Vashi Patel; Rachel W Winter; Walter W Chan; Jeffrey A Sparks
Journal:  BMJ Case Rep       Date:  2017-06-08

Review 3.  How the Frequency and Phenotype of Sarcoidosis is Driven by Environmental Determinants.

Authors:  Manuel Ramos-Casals; Belchin Kostov; Pilar Brito-Zerón; Antoni Sisó-Almirall; Robert P Baughman
Journal:  Lung       Date:  2019-06-12       Impact factor: 2.584

Review 4.  Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota.

Authors:  P Ungprasert; C S Crowson; E L Matteson
Journal:  Reumatismo       Date:  2017-05-22

5.  Inpatient Prevalence, Expenditures, and Comorbidities of Sarcoidosis: Nationwide Inpatient Sample 2013-2014.

Authors:  Patompong Ungprasert; Karn Wijarnpreecha; Wisit Cheungpasitporn; Charat Thongprayoon; Wuttiporn Manatsathit; Paul T Kröner
Journal:  Lung       Date:  2019-02-23       Impact factor: 2.584

Review 6.  [Sarcoidosis : Dermatological view of a rare multisystem disease].

Authors:  T Giner; S Benoit; H Kneitz; M Goebeler
Journal:  Hautarzt       Date:  2017-07       Impact factor: 0.751

7.  Prospective study of body mass index and risk of sarcoidosis in US women.

Authors:  Orianne Dumas; Krislyn M Boggs; Yvette C Cozier; Meir J Stampfer; Carlos A Camargo
Journal:  Eur Respir J       Date:  2017-10-19       Impact factor: 16.671

Review 8.  Epidemiology of sarcoidosis: current findings and future directions.

Authors:  Elizabeth V Arkema; Yvette C Cozier
Journal:  Ther Adv Chronic Dis       Date:  2018-08-24       Impact factor: 5.091

9.  Everyday cognitive failure in patients suffering from neurosarcoidosis.

Authors:  Mareye Voortman; Jolanda De Vries; Celine M R Hendriks; Marjon D P Elfferich; Petal A H M Wijnen; Marjolein Drent
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

10.  Type 2 diabetes risk in sarcoidosis patients untreated and treated with corticosteroids.

Authors:  Joshua P Entrop; Susanna Kullberg; Johan Grunewald; Anders Eklund; Kerstin Brismar; Elizabeth V Arkema
Journal:  ERJ Open Res       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.